Collaboration between hospital and community pharmacists to address drug-related problems: The HomeCoMe-program

被引:19
|
作者
Ensing, Hendrik T. [1 ,2 ,3 ]
Koster, Ellen S. [2 ]
Dubero, Dasha J. [2 ]
van Dooren, Ad A. [1 ]
Bouvy, Marcel L. [2 ]
机构
[1] Utrecht Univ Appl Sci, Res Grp Proc Innovat Pharmaceut Care, Utrecht, Netherlands
[2] Univ Utrecht, UIPS, Dept Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands
[3] Zorggrp Almere, Outpatient Pharm Brug 24-7, NL-1315 RA Almere, Netherlands
来源
关键词
Community pharmacist; Continuity of care; Patient safety; Home visit; Care transition; Drug-related problems; MEDICATION REVIEWS; PRIMARY-CARE; READMISSIONS; CONTINUITY; DISCHARGE; EVENTS; COMMUNICATION; MANAGEMENT; DIAGNOSIS; SEVERITY;
D O I
10.1016/j.sapharm.2018.05.001
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Hospital discharge poses a significant threat to the continuity of medication therapy and frequently results in drug-related problems post-discharge. Therefore, establishing continuity of care by realizing optimal collaboration between hospital and community pharmacists is of utmost importance. Objective: To evaluate the collaboration between hospital and community pharmacists on addressing drug-related problems after hospital discharge. Methods: A prospective follow-up study was conducted between November 2013-December 2014 in a general hospital and all affiliated community pharmacies. Adult patients, admitted for >= 48 h to the neurology or pulmonology ward were eligible if they used >= 3 chronic prescription drugs and lived in the community pharmacies' service area. The HomeCoMe intervention program was comprised of medication verification and counseling at admission, medication screening by the hospital pharmacist during admission, outpatient pharmacy discharge consultation and support, and a community pharmacist home visit within one week post-discharge. Results: The mean age of the 152 included patients was 67.0 +/- 12.6 years and 56.6% were female. A total of 745 DRPs (4.9 +/- 2.2 DRPs per patient, range: 0-11) were identified with the need for additional "Education or information" (36.1%) and "Compliance" (16.4%) issues as most common DRP-types. This led to a total of 928 recommendations (6.1 +/- 3.0 per patient, range: 1-19) to solve the DRP. The majority of DRPs were identified (83.6%, n=623) and solved (91.6%, n=682) by the community pharmacist during the home visit. Furthermore, 52.5% (n=64) of the DRPs identified during hospitalization were solved during the post-discharge home visit. Conclusions: Collaboration between hospital and community pharmacists from hospital admission to readmission to primary care is crucial to establish continuity of care. A post-discharge community pharmacist home visit is a valuable addition to in-hospital transitional care to identify and solve drug-related problems.
引用
收藏
页码:267 / 278
页数:12
相关论文
共 50 条
  • [1] Assessment of communication and drug-related problems by community pharmacists after hospital discharge
    Leemans, Lies
    Peeters, Muriel
    Vanderheyden, Christine
    Dupont, Alain G.
    Leys, Marc
    Saevels, Jan
    Sarre, Sophie
    Steurbaut, Stephane
    Verrydt, Ann
    Veroeveren, Luc
    [J]. PHARMACY WORLD & SCIENCE, 2009, 31 (02): : 307 - 307
  • [2] Impact of drug reconciliation at discharge and communication between hospital and community pharmacists on drug-related problems: a randomized controlled trial
    Pourrat, Xavier
    Roux, Clarisse
    Bouzige, Brigitte
    Garnier, Valerie
    Develay, Armelle
    Fraysse, Martial
    Halimi, Jean-Michel
    Allenet, Benoit
    Giraudeau, Bruno
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2017, 39 (01) : 212 - 213
  • [3] EFFECTS OF AN EDUCATION-PROGRAM FOR COMMUNITY PHARMACISTS ON DETECTING DRUG-RELATED PROBLEMS IN ELDERLY PATIENTS
    KIMBERLIN, CL
    BERARDO, DH
    PENDERGAST, JF
    MCKENZIE, LC
    [J]. MEDICAL CARE, 1993, 31 (05) : 451 - 468
  • [4] Characteristics of drug-related problems discussed by hospital pharmacists in multidisciplinary teams
    Hege Salvesen Blix
    Kirsten K. Viktil
    Tron Anders Moger
    Åsmund Reikvam
    [J]. Pharmacy World and Science, 2006, 28 : 152 - 158
  • [5] Characteristics of drug-related problems discussed by hospital pharmacists in multidisciplinary teams
    Blix, Hege Salvesen
    Viktil, Kirsten K.
    Moger, Tron Anders
    Reikvam, Asmund
    [J]. PHARMACY WORLD & SCIENCE, 2006, 28 (03): : 152 - 158
  • [6] Impact of drug reconciliation at discharge and communication between hospital and community pharmacists on drug-related problems: study protocol for a randomized controlled trial
    Xavier Pourrat
    Clarisse Roux
    Brigitte Bouzige
    Valérie Garnier
    Armelle Develay
    Benoit Allenet
    Martial Fraysse
    Jean-Michel Halimi
    Jacqueline Grassin
    Bruno Giraudeau
    [J]. Trials, 15
  • [7] Impact of drug reconciliation at discharge and communication between hospital and community pharmacists on drug-related problems: study protocol for a randomized controlled trial
    Pourrat, Xavier
    Roux, Clarisse
    Bouzige, Brigitte
    Garnier, Valerie
    Develay, Armelle
    Allenet, Benoit
    Fraysse, Martial
    Halimi, Jean-Michel
    Grassin, Jacqueline
    Giraudeau, Bruno
    [J]. TRIALS, 2014, 15
  • [8] Clinical knowledge of community pharmacists in Croatia for detecting drug-related problems
    Lovre Zekan
    Arijana Mestrovic
    Ana Seselja Perisin
    Mate Portolan
    Nada Jambrek
    Silvana Jager
    Martina Sepetavc
    Darko Modun
    [J]. International Journal of Clinical Pharmacy, 2017, 39 : 1171 - 1174
  • [9] Clinical knowledge of community pharmacists in Croatia for detecting drug-related problems
    Zekan, Lovre
    Mestrovic, Arijana
    Perisin, Ana Seselja
    Portolan, Mate
    Jambrek, Nada
    Jager, Silvana
    Sepetavc, Martina
    Modun, Darko
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2017, 39 (06) : 1171 - 1174
  • [10] Pharmacists in general practice: a focus on drug-related problems
    Helen Benson
    Cherie Lucas
    Walter Kmet
    Shalom I. Benrimoj
    Kylie Williams
    [J]. International Journal of Clinical Pharmacy, 2018, 40 : 566 - 572